Roger Gunn is Executive Vice President, Quantitative Data Science for Invicro, and Professor of Molecular Neuroimaging in the Division of Brain Sciences at Imperial College London.
He is currently working on an experimental medicine study for Dementias Platform UK examining 'glial' cells and their role in Alzheimer's disease.
He is also part of the Dementias Platform UK imaging network, and DPUK's Company Partner Forum.
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
Koychev, Ivana; Gunn, Roger N | Firouzian, Azadeh | Lawson, Jennifer | Zamboni, Giovanna | Ridha, Basil | Sahakian, Barbara J | Rowe, James B| Thomas, Alan | Rochester, Lynn | Ffytche, Dominic | Howard, Robert | Zetterberg, Henriki | MacKay, Clare| Lovestone, Simon | on behalf of the Deep and Frequent Phenotyping study team , (2018), Journal of Alzheimer's Disease
Gait in Mild Alzheimer’s Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study
Mc Ardle, Ríona et al, (2018), Journal of Alzheimer's Disease, 63, 331 - 341
Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451.
Firouzian A et al, (2018), 8
PET Tau and Amyloid-β Burden in Mild Alzheimer’s Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
Koychev, Ivan et al, (2017), Journal of Alzheimer's Disease, 60, 283 - 293